Glycogen synthase kinase-3 and Axin function in a beta-catenin-independent pathway that regulates neurite outgrowth

M H Orme1, A L Giannini, M D Vivanco

  • 1MRC Laboratory for Molecular Cell Biology, University College London, London, UK.

Insights

Lithium treatment and GSK-3 inhibition promote neurite outgrowth in Neuro-2a cells. This process involves Axin and GSK-3, but not beta-catenin-dependent transcription, suggesting a novel signaling pathway.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Molecular Signaling

Background:

  • The Wnt signaling pathway regulates beta-catenin stability and nuclear translocation, impacting gene transcription.
  • Glycogen synthase kinase-3 (GSK-3) phosphorylates beta-catenin, targeting it for degradation.
  • Neurite outgrowth is crucial for neuronal development and function.

Purpose of the Study:

  • To investigate the roles of beta-catenin and the Wnt signaling pathway in neurite outgrowth.
  • To elucidate the specific molecular mechanisms underlying lithium-induced neurite outgrowth in Neuro-2a cells.

Main Methods:

  • Utilized the Neuro-2a neuroblastoma cell line as a model system.
  • Administered lithium (Li(+)) and the GSK-3 inhibitor SB415286 to induce pathway activation.
  • Employed transfection techniques to manipulate beta-catenin and Axin levels.
  • Performed deletion analysis of Axin to identify critical functional domains.

Main Results:

  • Both Li(+) and SB415286 effectively induced neurite outgrowth in Neuro-2a cells.
  • Li(+)-induced neurite outgrowth proceeded independently of beta-catenin/TCF-dependent transcription.
  • Overexpression of beta-catenin did not induce neurite outgrowth.
  • Li(+) destabilized Axin, and ectopic Axin expression inhibited Li(+)-induced neurite outgrowth, dependent on the GSK-3 binding site.

Conclusions:

  • Neurite outgrowth induced by GSK-3 inhibition is regulated by a pathway involving Axin and GSK-3.
  • Beta-catenin and its transcriptional activity are not essential for lithium-induced neurite outgrowth in this model.
  • These findings reveal a novel signaling mechanism independent of canonical Wnt/beta-catenin pathways regulating neuronal differentiation.

Related Concept Videos

Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...